Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7202525 | 0.95 | TSHR (0.37) | TSHR | |
| SCHEMBL1482994 | 0.86 | CYP1A2 (0.41) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL11537702 | 0.84 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL11538423 | 0.84 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL11538435 | 0.84 | CYP1A2 (0.44) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL11538431 | 0.82 | CYP1A2 (0.36) | TSHRCYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL4446047 | 0.79 | CYP1A2 (0.34) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL8945726 | 0.71 | CYP1A2 (0.30) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL11616036 | 0.71 | DGKA (0.47) | TSHREPHX2DGKA | |
| SCHEMBL16418172 | 0.69 | PTPN7 (0.56) | EPHX2MAPTDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6607868-B2 | Dipropargyl acetamide | HYNIX SEMICONDUCTOR INC. (KR) | 2003-08-19 | — | — | US | disclosed |
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | CDH1, DDAH1, DPEP1 | TSHR 4702/4885EPHX2 1270/4885CYP1A2 1854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.